Search Results - "Kang, Yuqi"

Refine Results
  1. 1
  2. 2

    A kinase to cytokine explorer to identify molecular regulators and potential therapeutic opportunities by Chan, Marina, Kang, Yuqi, Osborne, Shannon, Zager, Michael, Gujral, Taranjit S

    Published in eLife (02-02-2024)
    “…Cytokines and chemokines are secreted proteins that regulate various biological processes, such as inflammation, immune response, and cell differentiation…”
    Get full text
    Journal Article
  3. 3

    HIV reprograms host m6Am RNA methylome by viral Vpr protein-mediated degradation of PCIF1 by Zhang, Qiong, Kang, Yuqi, Wang, Shaobo, Gonzalez, Gwendolyn Michelle, Li, Wanyu, Hui, Hui, Wang, Yinsheng, Rana, Tariq M.

    Published in Nature communications (20-09-2021)
    “…N 6 ,2′- O -dimethyladenosine (m 6 Am) is an abundant RNA modification located adjacent to the 5′-end of the mRNA 7-methylguanosine (m 7 G) cap structure. m 6…”
    Get full text
    Journal Article
  4. 4

    Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation by Olson, Annabel T, Kang, Yuqi, Ladha, Anushka M, Zhu, Songli, Lim, Chuan Bian, Nabet, Behnam, Lagunoff, Michael, Gujral, Taranjit S, Geballe, Adam P

    Published in PLoS pathogens (01-09-2023)
    “…Kaposi's sarcoma-associated herpesvirus (KSHV) causes several human diseases including Kaposi's sarcoma (KS), a leading cause of cancer in Africa and in…”
    Get full text
    Journal Article
  5. 5

    Atypical Hemolytic Uremic Syndrome-Associated FHR1 Isoform FHR1B Enhances Complement Activation and Inflammation by Xu, Boyang, Kang, Yuqi, Du, Yujing, Guo, Weiyi, Zhu, Li, Zhang, Hong

    Published in Frontiers in immunology (21-01-2022)
    “…Atypical hemolytic uremic syndrome (aHUS) is a rare but severe type of thrombotic microangiopathy that is triggered by the abnormal activation of the…”
    Get full text
    Journal Article
  6. 6

    Deep neural network modeling identifies biomarkers of response to immune-checkpoint therapy by Kang, Yuqi, Vijay, Siddharth, Gujral, Taranjit S.

    Published in iScience (20-05-2022)
    “…Immunotherapy has shown significant promise as a treatment for cancer, such as lung cancer and melanoma. However, only 10%–30% of the patients respond to…”
    Get full text
    Journal Article
  7. 7

    Hydrogen Sulfide Demonstrates Promising Antitumor Efficacy in Gastric Carcinoma by Targeting MGAT5 by Wang, Rui, Fan, Qilin, Zhang, Junjie, Zhang, Xunan, Kang, Yuqi, Wang, Zhirong

    Published in Translational oncology (01-08-2018)
    “…Mannosyl (alpha-1,6-)-Glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase (MGAT5) is exclusively expressed in gastric carcinoma, and plays an essential role…”
    Get full text
    Journal Article
  8. 8
  9. 9

    KIAA1429/VIRMA promotes breast cancer progression by m 6 A-dependent cytosolic HAS2 stabilization by Li, Na, Zhu, Zhouting, Deng, Yufei, Tang, Rachel, Hui, Hui, Kang, Yuqi, Rana, Tariq M

    Published in EMBO reports (09-10-2023)
    “…N -methyladenosine (m A), the most abundant internal modification in eukaryotic mRNA, plays important roles in many physiological and pathological processes,…”
    Get full text
    Journal Article
  10. 10

    Longitudinal correlates of bullying victimization among Chinese early adolescents: A cross-lagged panel network analysis by Li, Yuan, Kang, Yuqi, Zhu, Li, Yuan, Mengyuan, Li, Yonghan, Xu, Baoyu, Zhang, Xueying, Wang, Gengfu, Su, Puyu

    Published in Journal of affective disorders (15-10-2023)
    “…Bullying victimization is a major public health issue often faced by adolescents. This highlights the need to identify the relevant risk factors to inform…”
    Get full text
    Journal Article
  11. 11

    KIAA1429/VIRMA promotes breast cancer progression by m6A‐dependent cytosolic HAS2 stabilization by Li, Na, Zhu, Zhouting, Deng, Yufei, Tang, Rachel, Hui, Hui, Kang, Yuqi, Rana, Tariq M

    Published in EMBO reports (09-10-2023)
    “…N6‐methyladenosine (m6A), the most abundant internal modification in eukaryotic mRNA, plays important roles in many physiological and pathological processes,…”
    Get full text
    Journal Article
  12. 12

    A kinase to cytokine explorer to identify molecular regulators and potential therapeutic opportunities by Chan, Marina, Kang, Yuqi, Osborne, Shannon, Zager, Michael, Gujral, Taranjit S

    Published in eLife (02-02-2024)
    “…Cytokines and chemokines are secreted proteins that regulate various biological processes, such as inflammation, immune response, and cell differentiation…”
    Get full text
    Journal Article
  13. 13

    Mesangial C3 Deposition, Complement-Associated Variant, and Disease Progression in IgA Nephropathy by Kang, Yuqi, Xu, Boyang, Shi, Sufang, Zhou, Xujie, Chen, Pei, Liu, Lijun, Li, Yebei, Leng, Yueqi, Lv, Jicheng, Zhu, Li, Zhang, Hong

    “…IgA nephropathy is the most common primary GN worldwide, with dominant deposition of IgA and co-deposits of complement component 3 (C3). Phenotypes and…”
    Get more information
    Journal Article
  14. 14

    Abstract 616: Integrating organotypic tissue slices and polypharmacology-based screening to map the toxicity landscape of kinase inhibitors by Kang, Yuqi, Chan, Marina, Zhu, Songli, Gujral, Taranjit S.

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Abstract Protein kinases play important role in the regulation of various biological processes, and their malfunction and dysregulation are intricately linked…”
    Get full text
    Journal Article
  15. 15

    m 6 A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy by Wang, Lingling, Hui, Hui, Agrawal, Kriti, Kang, Yuqi, Li, Na, Tang, Rachel, Yuan, Jiajun, Rana, Tariq M

    Published in The EMBO journal (15-10-2020)
    “…An impressive clinical success has been observed in treating a variety of cancers using immunotherapy with programmed cell death-1 (PD-1) checkpoint blockade…”
    Get full text
    Journal Article
  16. 16

    m6A RNA methyltransferases METTL3/14 regulate immune responses to anti‐PD‐1 therapy by Wang, Lingling, Hui, Hui, Agrawal, Kriti, Kang, Yuqi, Li, Na, Tang, Rachel, Yuan, Jiajun, Rana, Tariq M

    Published in The EMBO journal (15-10-2020)
    “…An impressive clinical success has been observed in treating a variety of cancers using immunotherapy with programmed cell death‐1 (PD‐1) checkpoint blockade…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    KIAA1429/VIRMA promotes breast cancer progression by m6 A-dependent cytosolic HAS2 stabilization by Li, Na, Zhu, Zhouting, Deng, Yufei, Tang, Rachel, Hui, Hui, Kang, Yuqi, Rana, Tariq M

    Published in EMBO reports (09-10-2023)
    “…N6 -methyladenosine (m6 A), the most abundant internal modification in eukaryotic mRNA, plays important roles in many physiological and pathological processes,…”
    Get full text
    Journal Article
  20. 20